IDAC 10-K & 10-Q changes, risk factors and insider trading
Iron Dome Acquisition I Corp. (also IDACU, IDACW) · Nasdaq · Blank Checks · CIK 2090441 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..
What changed in the latest 10-Q
Risk Factors
Investing in our securities involves a high degree of risk. In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in our Registration Statement on Form S-1 filed with the SEC on January 30, 2026, as amended, which could materially affect our business, financial condition, or future results. As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Registration Statement.
Largest changes
Investing in our securities involves a high degree of risk. In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in our Registration Statement on Form S-1 filed with the SEC on January 30, 2026, as amended, which could materially affect our business, financial condition, or future results.see in full comparisonresults.As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Registration Statement.
Full comparison: every changed paragraph (1)
Investing in our securities
involves a high degree of risk. In addition
to the other information set forth in this Quarterly Report, you should carefully consider
the factors discussed in our Registration Statement
on Form S-1 filed with the SEC on January 30, 2026, as amended, which could materially
affect our business, financial condition, or future
results. results.As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the
Registration Statement.
Management's Discussion & Analysis (MD&A)
Largest changes
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regardingsee in full comparisonthe completion of the Proposed Business Combination (as defined below),the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-lookingstatements, includingthat the conditions of the Proposed Business Combination are not satisfied.statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
“On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000, less deferred underwriting commission of $420,000.”see in full comparison
“The underwriter is entitled to a deferred underwriting commission of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), payable upon completion of the Business Combination. The deferred underwriting commission is subject to adjustment based on redemptions, if any, of Class A ordinary shares. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.”see in full comparison
Simultaneously with the closing of the Initial Public Offering, wesee in full comparison(i)completed the private sale of 2,750,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $2,750,000 (the “Private Placement”). The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering.On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.
“Additionally, the underwriter is entitled to a fixed fee of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), for advisory fees payable upon completion of the Business Combination. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.”see in full comparison
“For the six months ended June 30, 2026, cash used in operating activities was $39,969, which consisted of net income of $629,213, offset by investment income on investments held in Trust of $656,771, change in the over-allotment option of $212,823 and the net change in assets and liabilities of $200,412.”see in full comparison
Full comparison: every changed paragraph (18)
This Quarterly Report includes
“forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange
Act that are not historical facts and
involve risks and uncertainties that could cause actual results to differ materially from those
expected and projected. All statements,
other than statements of historical fact included in this Form 10-Q including, without limitation,
statements in this “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” regarding
the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business
strategy and
the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,”
“believe,”
“anticipate,” “intend,” “estimate,” “seek” and variations and similar
words and expressions
are intended to identify such forward-looking statements. Such forward-looking statements relate to future events
or future performance,
but reflect management’s current beliefs, based on information currently available. A number of factors could
cause actual events,
performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including
that the conditions of the Proposed Business Combination are not satisfied.statements. For information identifying important factors that could
cause actual results to differ materially from those anticipated
in the forward-looking statements, please refer to the Risk Factors
section of the Company’s Registration Statement on Form S-1
filed with the U.S. Securities and Exchange Commission (the “SEC”).
The Company’s securities filings can be accessed
on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly
required by applicable securities law, the Company
disclaims any intention or obligation to update or revise any forward-looking statements
whether as a result of new information, future
events or otherwise.
We are a blank check company
incorporated as a Cayman Islands exempted
company on September 5, 2025 for the purpose of effecting a merger, amalgamation, share exchange,
asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses, which we refer to throughout
this Quarterly Report as our initial business
combination. We have not selected any specific business combination target, and we have
not, nor has anyone on our behalf, engaged in
any substantive discussions, directly or indirectly, with any business combination target
with respect to an initial business combination
with us. We intend to effectuate our initial business combination using cash from the
proceeds of the initial public offering (the “Initial
Public Offering”) and the sale of the private placement warrants (the
“Private Placement”) and the proceeds of the sale
of our securities in connection with our initial business combination (pursuant
to any the forward purchase agreements, backstop or similar
agreements we may enter into following the consummation of the Initial Public
Offering or otherwise), our shares, debt or a combination
of cash, equity and debt.
We have neither engaged in
in any operations nor generated any revenues to date. Our only activities from September 5, 2025 (inception) through MarchJune 31,30, 2026 were organizational
organizational activities and those necessary to prepare for the Initial Public Offering. Following the Initial Public Offering, we will
continue not
to generate any operating revenues until after completion of our initial business combination. We will continue to generate non-operating
non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and the Private Placement
held in the
Trust Account. There has been no significant change in our financial or trading position and no material adverse change has
occurred since
the date of our audited financial statements. After the Initial Public Offering, we will continue to incur increased expenses
as a result
of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence
expenses.
For the three and six months ended June 30, 2026, we had a net income of $629,213, which primarily includes $656,771 of income earned on cash held in Trust and change in fair value of overallotment option of $212,823, partially offset by formation and operating expenses of $240,381.
For the three months ended
March 31, 2026, we had a net loss of $0.
As of June 30, 2026, we had cash of $767,364 held outside the Trust Account and working capital of $1,086,331. Until the consummation of the Initial Public Offering, our only sources of liquidity were an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and a loan from the Sponsor, of up to $300,000 under an unsecured, non-interest bearing promissory note, which was repaid on May 18, 2026.
Subsequent to the quarterly
period covered by this Quarterly Report, onOn May 18, 2026, we consummated the Initial Public Offering of 15,000,000
Units (the “Public
Units” and, with respect to the Class A ordinary shares and public warrants included in the Public Units,
the “Public Shares”,
and “Public Warrants”, respectively). The Units were sold at a price of $10.00 per Unit,
generating gross proceeds to the
Company of $150,000,000.
Simultaneously with the
closing of the Initial Public Offering, we (i)
completed the private sale of 2,750,000 warrants (the “Private Placement Warrants”)
to the Sponsor at a purchase price of
$1.00 per Private Placement Warrant, generating gross proceeds to the Company of $2,750,000 (the
“Private Placement”). The
Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering.
On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”).
The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026.
The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.
On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000, less deferred underwriting commission of $420,000.
In order to finance transaction
costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working
Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest,
or, at the lender’s discretion, up to $2,000,000 of the notes may be converted into Class A ordinary shares of the post-business
combination entity at a price of $10.00 per share at the option of the Sponsor. In the event that a Business Combination does not close,
the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the
the Trust Account would be used to repay the Working Capital Loans. As of MarchJune 31,30, 2026, there was no amount outstanding under
the Working
Capital Loans.
For the six months ended June 30, 2026, cash used in operating activities was $39,969, which consisted of net income of $629,213, offset by investment income on investments held in Trust of $656,771, change in the over-allotment option of $212,823 and the net change in assets and liabilities of $200,412.
For the six months ended June 30, 2026 cash used in investing activities was $157,785,000, which consisted of the funds deposited into the Trust.
For the six months ended June 30, 2026 cash provided by financing activities was $158,592,333, which consisted of the proceeds from the Initial Public Offering and private placement, partially offset by offering costs.
As of theJune three months ended
March 31,30, 2026, we did
not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have
any commitments or contractual
obligations.
The Company granted the
underwriter a 45-day option from the date of
the Initial Public Offering to purchase up to 2,250,000 additional Units to cover over-allotments,
if any, at the Initial Public Offering.Offering
price, less underwriting discounts and commissions. On May 19, 2026, the underwriter partially exercised the over-allotment option for
700,000 Units.
The closing of the Over-Allotment Option Units occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment
Option Option
Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.
The underwriter is entitled to a deferred underwriting commission of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), payable upon completion of the Business Combination. The deferred underwriting commission is subject to adjustment based on redemptions, if any, of Class A ordinary shares. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.
Additionally, the underwriter is entitled to a fixed fee of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), for advisory fees payable upon completion of the Business Combination. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.
The preparation of the unaudited
condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States
of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods
periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate
estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management
management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly,
the actual
results could materially differ from those estimates. As of MarchJune 31,30, 20262026, we had the following critical accounting estimates: fair value
of public and Decemberprivate 31, 2025, we did not have any critical
accounting estimates.warrants..
IDAC insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding IDAC (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Millennium Management (Israel Englander) | 2026-06-30 | 600,000 | $6.1M | 0.0% | New position |
| Two Sigma Investments | 2026-06-30 | 271,875 | $2.7M | 0.0% | New position |